~" The authors report the results of inhibition ofthromboxane A2 synthetase in 49 consecutive patients with subarachnoid hemorrhage (SAH). These unselected Grade I to IV patients all had a ruptured aneurysm of the anterior circle of Willis, and were operated on within 72 hours after SAH. Twenty-seven patients were treated postoperatively by an intravenous infusion of sodium(E)-3-[4-(3-pyridylmethyl)-phenyl]-2-propenoate (OKY-1581), a selective inhibitor of thromboxane Az synthetase, at 5 ug/kg/min for 10 to 14 days, and the remaining 22 patients did not receive this drug. Both groups of patients had similar age distribution and preoperative neurological conditions. A suggestive but statistically insignificant improvement was found in postoperative angiographic vasospasm, ischemic symptoms, and overall outcome in the group receiving OKY-1581. The incidence of low-density areas on the postoperative computerized tomography scans was significantly decreased in patients treated with OKY-1581 infusion.
T HE timing of surgical intervention for ruptured intracranial aneurysms remains the focus of a major controversy. Early surgery has been proposed increasingly often in an attempt to prevent rebleeding and avoid ischemic insult by removal of subarachnoid blood. 11 '13'16-18'2~ The subarachnoid blood clot is often so firm that virtually none can be removed without risking injury to important vessels, and a complete removal of subarachnoid clot may be practically impossible. Postoperative ischemic symptoms, even though decreased in incidence, often appear after the removal of subarachnoid clot in early operation. ~ 1,~8,20,34,38 In a previous study of experimental delayed vasospasm, 6 an intravenous infusion of sodium(E)-3-[4-(3-pyridylmethyl)-phenyl]-2-propenoate (OKY-1581) did not significantly reverse angiographic vasospasm, but increased the mean difference between regional cerebral blood flows (rCBF's) without any serious changes in mean arterial blood pressure and pulse rate. On the basis of these experimental results, the present preliminary clinical study reports the results in patients who were operated on within 72 hours after rupture of an aneurysm and treated with postoperative intravenous OKY-15 81 infusion. These results were compared with findings in similar patients not treated with OKY-1581.
Clinical Material and Methods
This study included 49 consecutive unselected Grade I to IV patients with ruptured aneurysms of the anterior circle of Willis, who were operated on within 72 hours after subarachnoid hemorrhage (SAH). Postoperatively, 22 patients (Group A) were treated with hypertensive hypervolemic therapy, 23 and 27 patients (Group B) were treated by an intravenous infusion of OKY-1581 at 5 ug/kg/min for 10 to 14 days.* The distributions of age and aneurysm site, and the preoperative clinical status classified according to Hunt and Hess, j2 are shown in Tables 1 and 2 . Contrary to the recommendation of Hunt and Hess, no adjustment in clinical grade has been made in light of significant systemic disease. None of the patients showed preoperative vasospasm on angiography. Preoperative SAH as visualized by computerized tomography (CT) was graded according to the 4 The presence of low-density areas due to delayed vasospasm was again assessed on CT scans 1 month after surgery. In addition, postoperative symptomatic vasospasm was assessed by neurological examination. Standard microsurgical technique was used for surgery via the pterional approach to obliterate the aneurysm without temporary clipping. Hypotension was induced; brain slackness was achieved with mannitol (1 gm/kg), furosemide (0.5 mg/kg), and hyperventilation to a PaCO2 of 25 to 30 torr; ventricular drainage was added to some cases. The suprasellar cistern, the interhemispheric fissure near the anterior communicating artery, and the unilateral stem of the Sylvian fissure and Sylvian cistern were opened. Any blood clots in those cisterns were removed as far as possible. Blood pressure and pulse rate as well as hematological status were monitored. Postoperative ventriculoperitoneal shunts were placed in four cases in Group A and in eight cases in Group B.
Clinical outcome was determined at follow-up examination a minimum of 6 months after surgery (Table  4) . "Favorable outcome" corresponded to good recovery on the Glasgow Outcome Scale 15 in which the "patient can lead a full and independent life with or without minimal neurological deficit." Patients with an "unfavorable result" were not independent, or had a major neurological deficit. For the purpose of this study, the number of deaths included only those patients dying directly of central nervous system disease or from other causes related to the surgical procedure, such as pneumonia, sepsis, and coagulopathy. Statistical analysis was assessed by the Fisher exact probability test. 29
Results

Effect of OKY-1581 on Angiographic Vasospasm
Postoperative angiography was performed in 19 patients in Group A (without OKY-1581) and in 22 patients in Group B (with OKY-1581). The correlation of the preoperative CT finding of SAH and postoperative angiographic vasospasm is shown in Table 5 . No patients fell within Grade 1 on the preoperative CT scan. Postoperative angiographic vasospasm was frequently seen in SAH Grade 3 patients. The incidence of postoperative angiographic vasospasm was 84% (16 of 19 cases) in Group A and 77% (17 of 22 cases) in Group B; severe and slight to moderate vasospasm were found in 47% and 37% in Group A and 23% and 54% in Group B, respectively. Although the incidence of severe vasospasm was lower in Group B, there was no statistical significance in the incidence of severe or slight to moderate vasospasm between both groups. In three patients in Group A and five patients in Group B who t Numbers in parentheses indicate hematoma patients and location of the hematoma. C = intracerebral hematoma; V = intraventricular hematoma; S = subdural hematoma.
:~ Statistically significant by Fisher exact probability test. did not undergo postoperative angiography, a postoperative low-density area was found on CT scanning in one patient in Group A and two patients in Group B.
Effect of OKY-1581 on CT Low-Density Areas
The incidence of postoperative ischemic symptoms, both transient and permanent, was 18% (four of 22 cases) and 32% (seven of 22 cases) in Group A and 11% (three of 27 cases) and 15% (four of 27 cases) in Group B, respectively, as shown in Table 4 . No statistical significance was found in postoperative transient and permanent ischemic symptoms between both groups. The occurrence of delayed postoperative vasospasm visible on CT scanning was 45 % (10 of 22 cases) in Group A and 15% (four of 27 cases) in Group B. The incidence of postoperative vasospasm in Group B was significantly (p < 0.05) lower than that in Group A. The low-density areas were small in two cases, moderate in seven cases, and large in one case in Group A, and small in two cases, moderate in 1 case, and large in one case in Group B. In seven patients with transient ischemic symptoms, low-density areas were found in only two Group A patients; low-density areas were found in all 11 patients who showed permanent ischemic symptoms. One patient in Group A with a small area of low density in the left caudate nucleus had no evidence of symptomatic vasospasm. One patient in Group B who did not demonstrate symptomatic vasospasm or a low-density area died from renal failure.
Effect of OKY-1581 on Postoperative Outcome
Of the 22 patients in Group A, 17 (77%) had a favorable outcome, three (14%) had an unfavorable outcome, and two (9%) died. Of the 27 patients in Group B, 23 (85%) had a favorable outcome, two (7%) had an unfavorable outcome, and two (7%) died. Although no statistical significance was evident among patients with a favorable outcome between Groups A and B, the incidence of favorable outcome was increased in Group B as compared to that in Group A, and seemed to be mainly due to a better postoperative result in neurological Grade III patients. The vasospasm was located in a silent area and was associated with a favorable outcome in five cases in Group A and in two cases in Group B. The overall outcome of patients with intracerebral and intraventricular hematomas is shown in Table 4 . Two patients with temporal hematoma in Group A, and three patients with temporal hematoma, one patient with frontal hematoma, and one patient with subdural hematoma in Group B all enjoyed a favorable outcome.
Other Effects of OKY-1581
The mean values of systolic and diastolic blood pressures and pulse rate before and during OKY-1581 infusion were 137 _+ 17 mm Hgand 141 + 15 mm Hg, 76+ 11 mmHgand81 + 11 mmHg, and81 + 11 beats/min and 77 + 11 beats/min, respectively. By Student t-test analysis, no significant effect of OKY-1581 was evident on blood pressure and pulse rate. Infusion of OKY-1581 for 14 days induced a thrombocytopenia in two patients, which was, however, promptly normalized by the interruption of OKY-1581 treatment.
Discussion
Pharmacology of OKY-1581
OKY-1581 is a selective inhibitor of thromboxane A2 (TXA2) synthetase. 1' 7' 9' 14' 3~ The concentration of OKY-1581 required to induce 50% inhibition (IDso) of TXA2 synthesis in rabbit platelets is 3 l0 -9 M 9. In addition, the molecular weight and the half-life of OKY-1581 are 275 and 10 minutes, respectively. 9 Consequently, the concentration of OKY-158I when infused at 5 ug/kg/min for l0 to 14 days may theoretically be enough to inhibit TXA2 synthesis nearly completely (J Naito, personal communication). Serum concentrations ofthromboxane B2 (TXB2: breakdown product of TXA2), prostaglandin (PG) E, and PGF are changed from 126 _+ 66 ng/ml, 3 _+ 4 ng/ml, and 10 _+ 8 ng/ml to 5 _+ 1 ng/ml, 70 _+ 18 ng/ml, and 63 + 2 ng/ml, respectively, at 2 hours after subcutaneous administration of 100 mg of OKY-1581 in rabbits. 3~ An intravenous infusion of OKY-1581 at l0 to 1000 ug/kg/min for 1 hour in anesthetized baboons decreases the TXB2 plasma level and increases the level of 6-keto PGFI~ (breakdown product of prostacyclin (PGI2)) in most animalsY Oral administration of OKY-1581 in humans and monkeys causes a dose-dependent inhibition of serum TXB2.1o '14 
Effect of OKY-1581 on Angiographic Vasospasm
The present study suggests that postoperative anglographic vasospasm is not significantly reversed with OKY-1581 infusion, although the degree of vascular narrowing due to vasospasm appears more mild in Group B patients (with the drug) than in Group A patients (without the drug). The appearance of postoperative angiographic vasospasm is partly dependent upon the timing of angiography, the reactivity of individual vessels, and the amount of blood clot around the vessels. Although PGI2 synthesis in the cerebral artery is markedly decreased in experimental delayed vasospasm, TXA2 formation is not detected in the normal and spastic cerebral arteries with thin-layer chromatography. 19 In addition, intravenous infusion of OKY-1581 at 50 ug/kg/min for 2 hours or PGI2 at 25 or 75 ng/kg/min for 15 minutes in experimental delayed vasospasm does not significantly reverse angiographic vasospasm.5'6
Effect of OKY-1581 on CT Low-Density Areas
The incidence of postoperative ischemia in Group A is comparable to that in other studies after early surgery, 16,18,20,34,38 and the incidence of postoperative ischemia in Group B is insignificantly decreased as compared to that in Group A. A good correlation is not always found between the postoperative occurrence ofischemic symptoms and low density on CT scans, mainly because of the location and the size of the low-density area. Since the low-density area on the CT scans assessed in the present study is associated with postoperative delayed vasospasm, it seems reasonable to assume that the occurrence of postoperative ischemia is faithfully represented by the area of low density on the CT scan. The postoperative incidence (15%) of low density on Group B CT scans is significantly decreased as compared to that in Group A (45%). In experimental delayed vasospasm, OKY-1581 infusion at 50 ug/kg/min for 1 or 2 hours increased the mean regional cerebral blood flow insignificantly and the mean difference of rCBF significantly. 5
Effect of OKY-1581 on Overall Outcome
It has been reported that the mean percentage of favorable and unfavorable outcomes and deaths after early operation are 76.3% (69.3% to 84.5%), 15.5% (8% to 25%), and 8.7% (0% to 16%), respectively. 16-18' 20,27,32,34,38 The favorable and unfavorable outcomes and deaths in Group A are comparable to those reported in other clinics. When treated with OKY-1581 postoperatively, favorable outcome patients are increased in number; in particular, the overall outcome of Grade III patients in Group B is better than that in Group A. On the contrary, there is virtually no difference in overall outcome of Grade IV patients between both groups. The intracerebral or the intraventricular hematoma, except temporal hematoma, is often unfavorably associated with the preoperative clinical status and the postoperative overall outcome. 18 ' 21' 36 
Pharmacological Effect of OKY-1581 on Delayed Vasospasm
In 119 autopsy cases in which cerebral infarction occurred following ruptured aneurysm, endothelial damage was a prominent feature and was observed to extend back into sizable arterial branches. 3 The arteries with endothelial damage were not thrombosed but were associated with cerebral infarction? OKY-1581 was found to block platelet aggregation induced by arachidonic acid or collagen in rabbits and humans, 1'7'9'1~176 and prevented experimental thrombosis induced by arachidonic acid and AgNO3. 9"1~ However, the mean platelet aggregation rate induced by collagen and the mean percent inhibition of platelet aggregation during OKY-1581 infusion at 50 ~tg/kg/min for 2 hours in spastic animals were not significant as compared to those in normal animals, and the increase in rCBF by OKY-1581 infusion in spastic animals was not due to the inhibition of platelet aggregation) Shohami, et al., 28 studied rats subjected to severe incomplete cerebral ischemia, and reported that PGE2 accumulated in the brain tissue during the first 5 minutes of ischemia, and then declined at 15 minutes; however, the level of TXB2 in the brain tissue remained high during the whole time course of the experiment. The increased synthesis of PGEz or TXA2 in the ischemic brain tissue may constrict the local blood vessels 2z'37 and diminish the local blood flow, 24'39 but actually the parenchymal vessels dilated and CBF decreased in vasospasm. 8 Similar PG products may be produced in the ischemic brain tissue in vasospasm, but the local microcirculation in vasospasm could be inexplicable only on the basis of the disturbed PG metabolism. However, it has been shown that treatment with indomethacin prior to incomplete cerebral ischemia reduces the levels of PGE2 and TXB2 in rat ischemic brain tissue and accelerates electroencephalographic recovery after reperfusion, suggesting that indomethacin improves the postischemic reflowY Thus, the increased production of TXA2 that may occur in the ischemic brain tissue in vasospasm may diminish by treatment with OKY-1581, thereby ameliorating the local microcirculation.
Although the number of cases in the present study is too small to allow a firm conclusion about the pharmacological effect of OKY-1581 on delayed vasospasm, the incidence of low-density areas on postoperative CT scans is significantly decreased with OKY-1581 infusion, indicating a substantial increase in rCBF above the critical level, 15 to 20 ml/100 gm/min, 2,3~' 33 particularly in postoperative Grade I to III patients, as suggested by a previous experimental study. 5 Thrombocytopenia was found in two of 27 patients during OKY-1581 infusion. Consequently, development of other selective inhibitors of TXA2 synthetase, such as (E)-3-[4-(1-imidazolylmethyl)phenyl]-2-propenoic acid hydrochloride monohydrate (OKY-046), 5 is necessary.
